HTA71 Cost-effectiveness of The Top 100 Drugs By Public Spending in Canada, 2015-2021: A Repeated Cross-sectional Study

Abstract

Authors

E Gaudette S Rizzardo Y Zhang M Tadrous K Pothier

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×